Dudediligence.

Quince Therapeutics, Inc

QNCXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$5.5MSep ’24−$12.5MDec ’24−$15.0MMar ’25−$16.0MJun ’25−$13.4MSep ’25−$39.5MDec ’25$35.9MMar ’26−$75.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$90.3M−$52.0M−$34.6M−$57.3M−$58.1M
Net income−$89.9M−$51.7M−$31.4M−$56.8M−$84.0M
Operating cash flow−$62.9M−$44.0M−$18.3M−$31.9M−$41.4M
Free cash flow−$63.1M−$44.2M−$18.5M−$32.2M−$41.8M
Cash$69.7M$44.6M$20.8M$6.2M$5.8M
Debtnone on file$0.00$13.4M$14.3M$18.0M
Shares outstanding30.1M36.1M43.0M44.0M55.7M